{
    "Trade/Device Name(s)": [
        "QUANTA Flash HMGCR Reagents"
    ],
    "Submitter Information": "Inova Diagnostics, Inc.",
    "510(k) Number": "K180975",
    "Predicate Device Reference 510(k) Number(s)": [
        "K151429"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LLL"
    ],
    "Summary Letter Date": "April 12, 2018",
    "Summary Letter Received Date": "April 13, 2018",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5100"
    ],
    "Regulation Name(s)": [
        "Antinuclear antibody immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "IgG autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BIO-FLASH"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay",
        "Microparticle immunoassay"
    ],
    "Methodologies": [
        "Solid phase immunoassay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for QUANTA Flash HMGCR Reagents, a chemiluminescent immunoassay for detection of anti-HMGCR IgG autoantibodies using the BIO-FLASH platform.",
    "Indications for Use Summary": "Semi-quantitative determination of IgG autoantibodies against HMGCR in human serum as an aid in the diagnosis of idiopathic inflammatory myopathy (IIM), used in conjunction with clinical findings and other laboratory tests.",
    "fda_folder": "Immunology"
}